Pfizer Inc has started an early-stage U.S. trial of an oral COVID-19 antiviral therapy that could be prescribed to patients at the first sign of infection, the company said on…

Read more »

The post Pfizer Begins Early-Stage Study of Oral COVID-19 Drug appeared first on Hamodia.

In related news:

  1. Poll: Cost Makes Nearly 1 in 10 Leery of Seeking COVID Care
  2. Fauci, CDC Chief Raise Concerns About Full Flights
  3. Retailers to Governors: Please Mandate Face Mask Wearing
  4. Moderna Says Its COVID-19 Vaccine Is 94.5% Effective
  5. Pentagon Approves 20 More COVID-19 Vaccination Teams